Literature DB >> 32277902

The knowns and unknowns of treatment for alcoholic hepatitis.

Tejasav S Sehrawat1, Mengfei Liu1, Vijay H Shah2.   

Abstract

Alcoholic hepatitis is an acute, inflammatory liver disease associated with high morbidity and mortality both in the short term and long term. Alcoholic hepatitis often arises in patients with a background of chronic liver disease and it is characterised by the rapid onset of jaundice and the development of myriad complications. Medical therapy for severe alcoholic hepatitis relies on corticosteroids, which have modest effectiveness. Abstinence from alcohol is critically important in patients with alcoholic hepatitis, but recidivism is high. Because of the absence of effective medical treatments for alcoholic hepatitis and alcohol dependency, there is a pressing need to develop new and effective therapeutics. Supported by promising preliminary and preclinical studies, many ongoing clinical trials of new therapies for alcoholic hepatitis are currently underway and are discussed further in this Series paper.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32277902      PMCID: PMC7238289          DOI: 10.1016/S2468-1253(19)30326-7

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


  76 in total

1.  Alcohol Rehabilitation Within 30 Days of Hospital Discharge Is Associated With Reduced Readmission, Relapse, and Death in Patients With Alcoholic Hepatitis.

Authors:  Thoetchai Bee Peeraphatdit; Patrick S Kamath; Victor M Karpyak; Brian Davis; Vivek Desai; Suthat Liangpunsakul; Arun Sanyal; Naga Chalasani; Vijay H Shah; Douglas A Simonetto
Journal:  Clin Gastroenterol Hepatol       Date:  2019-04-28       Impact factor: 11.382

Review 2.  Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis.

Authors:  Thomas Greuter; Harmeet Malhi; Gregory J Gores; Vijay H Shah
Journal:  JCI Insight       Date:  2017-09-07

Review 3.  Non-invasive diagnosis and biomarkers in alcohol-related liver disease.

Authors:  Christophe Moreno; Sebastian Mueller; Gyongyi Szabo
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

Review 4.  Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.

Authors:  Charles S Lieber
Journal:  Alcohol       Date:  2004-08       Impact factor: 2.405

5.  Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study.

Authors:  Virendra Singh; Arun K Sharma; R Lakshmi Narasimhan; Ashish Bhalla; Navneet Sharma; Ratiram Sharma
Journal:  Am J Gastroenterol       Date:  2014-06-17       Impact factor: 10.864

6.  Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial.

Authors:  Laurent Spahr; Jean-François Lambert; Laura Rubbia-Brandt; Yves Chalandon; Jean-Louis Frossard; Emiliano Giostra; Antoine Hadengue
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

7.  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.

Authors:  Giovanni Addolorato; Lorenzo Leggio; Anna Ferrulli; Silvia Cardone; Luisa Vonghia; Antonio Mirijello; Ludovico Abenavoli; Cristina D'Angelo; Fabio Caputo; Antonella Zambon; Paul S Haber; Giovanni Gasbarrini
Journal:  Lancet       Date:  2007-12-08       Impact factor: 79.321

8.  ACG Clinical Guideline: Alcoholic Liver Disease.

Authors:  Ashwani K Singal; Ramon Bataller; Joseph Ahn; Patrick S Kamath; Vijay H Shah
Journal:  Am J Gastroenterol       Date:  2018-01-16       Impact factor: 10.864

9.  Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals.

Authors:  Shashi Bala; Miguel Marcos; Arijeet Gattu; Donna Catalano; Gyongyi Szabo
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

10.  The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.

Authors:  Michael Trauner; Aliya Gulamhusein; Bilal Hameed; Stephen Caldwell; Mitchell L Shiffman; Charles Landis; Bertus Eksteen; Kosh Agarwal; Andrew Muir; Simon Rushbrook; Xiaomin Lu; Jun Xu; Jen-Chieh Chuang; Andrew N Billin; Georgia Li; Chuhan Chung; G Mani Subramanian; Robert P Myers; Christopher L Bowlus; Kris V Kowdley
Journal:  Hepatology       Date:  2019-03-10       Impact factor: 17.425

View more
  21 in total

1.  An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis.

Authors:  Juan P Arab; Tejasav S Sehrawat; Douglas A Simonetto; Vikas K Verma; Dechun Feng; Tom Tang; Kevin Dreyer; Xiaoqiang Yan; William L Daley; Arun Sanyal; Naga Chalasani; Svetlana Radaeva; Liu Yang; Hugo Vargas; Mauricio Ibacache; Bin Gao; Gregory J Gores; Harmeet Malhi; Patrick S Kamath; Vijay H Shah
Journal:  Hepatology       Date:  2020-04-27       Impact factor: 17.425

2.  Identification of a protective Bacteroides strain of alcoholic liver disease and its synergistic effect with pectin.

Authors:  Qiangqiang Wang; Yating Li; Longxian Lv; Huiyong Jiang; Ren Yan; Shuting Wang; Yanmeng Lu; Zhengjie Wu; Jian Shen; Shiman Jiang; Jiawen Lv; Shengjie Li; Aoxiang Zhuge; Lanjuan Li
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-13       Impact factor: 4.813

3.  Outcomes of Hospitalized Acute Alcoholic Hepatitis (AH) in Patients With Bipolar 1 Disorder (B1D).

Authors:  Alexander J Kaye; Shivani Patel; Sarah Meyers; Daniel Rim; Catherine Choi; Sushil Ahlawat
Journal:  Cureus       Date:  2022-05-27

Review 4.  Interleukin-22 in alcoholic hepatitis and beyond.

Authors:  Xiaogang Xiang; Seonghwan Hwang; Dechun Feng; Vijay H Shah; Bin Gao
Journal:  Hepatol Int       Date:  2020-09-05       Impact factor: 6.047

5.  XIAP Knockdown in Alcohol-Associated Liver Disease Models Exhibits Divergent in vitro and in vivo Phenotypes Owing to a Potential Zonal Inhibitory Role of SMAC.

Authors:  Li He; Tejasav S Sehrawat; Vikas K Verma; Amaia Navarro-Corcuera; Guneet Sidhu; Amy Mauer; Xin Luo; Tomohiro Katsumi; Jingbiao Chen; Soni Shah; Juan Pablo Arab; Sheng Cao; Hamid Kashkar; Gregory J Gores; Harmeet Malhi; Vijay H Shah
Journal:  Front Physiol       Date:  2021-05-07       Impact factor: 4.755

Review 6.  Regulation and functional roles of chemokines in liver diseases.

Authors:  Sheng Cao; Mengfei Liu; Tejasav S Sehrawat; Vijay H Shah
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-11       Impact factor: 73.082

7.  Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis.

Authors:  Tejasav S Sehrawat; Juan P Arab; Mengfei Liu; Pouya Amrollahi; Meihua Wan; Jia Fan; Yasuhiko Nakao; Elisa Pose; Amaia Navarro-Corcuera; Debanjali Dasgupta; Chieh-Yu Liao; Li He; Amy S Mauer; Emma Avitabile; Meritxell Ventura-Cots; Ramon A Bataller; Arun J Sanyal; Naga P Chalasani; Julie K Heimbach; Kymberly D Watt; Gregory J Gores; Pere Gines; Patrick S Kamath; Douglas A Simonetto; Tony Y Hu; Vijay H Shah; Harmeet Malhi
Journal:  Hepatology       Date:  2020-10-30       Impact factor: 17.425

Review 8.  Malnutrition and Alcohol-Associated Hepatitis.

Authors:  Craig J McClain; Cristian D Rios; Sally Condon; Luis S Marsano
Journal:  Clin Liver Dis       Date:  2021-05-26       Impact factor: 6.126

Review 9.  Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives.

Authors:  Szu-Yi Liu; I-Ting Tsai; Yin-Chou Hsu
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

Review 10.  Moderate Alcoholic Hepatitis.

Authors:  Ana Clemente-Sánchez; Aline Oliveira-Mello; Ramón Bataller
Journal:  Clin Liver Dis       Date:  2021-05-27       Impact factor: 6.265

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.